Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale et autres
18 citationsThe Lancet Global Health